Uma Ramesh

Ms. Uma Ramesh

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ECElizabeth Chiang
Elizabeth Chiang
HSHaleigh Dawn Stafford
Haleigh Dawn Stafford
JBJane Buell
Jane Buell
URUma Ramesh
Uma Ramesh
Moran AmitMoran Amit
Moran Amit
DYDan Yaniv
Dan Yaniv
It is widely known that tumor cells of basal and squamous cell carcinoma interact with the cellular and acellular components of the tumor microenvironment to promote tumor growth and progression. While this environment differs for basal and squamous cell carcinoma, the cellular players within both create an immunosuppressed environment by downregulating effector CD4+ and CD8+ T cells and promoting the release of pro-oncogenic Th2 cytokines. Understanding the crosstalk that occurs within the tumor microenvironment has led to the development of immunotherapeutic agents, including vismodegib and cemiplimab to treat BCC and SCC, respectively. However, further investigation of the TME will provide the opportunity to discover novel treatment options.

18 October 2023 in Head & Neck
Verified
Journal Article
Closed access
URUma Ramesh
Uma Ramesh
KCKevin J. Contrera
Kevin J. Contrera
NSNasim Shakibai
Nasim Shakibai
SSShirley Y. Su
Shirley Y. Su
BBBledi Brahimaj
Bledi Brahimaj
EHEhab Y. Hanna
Ehab Y. Hanna

17 August 2024 in Cancers
Verified
Journal Article
Open access
PDF file
URUma Ramesh
Uma Ramesh
ECElizabeth Chiang
Elizabeth Chiang
HSHaleigh Dawn Stafford
Haleigh Dawn Stafford
JBJane Buell
Jane Buell
FMFrank Thomas Materia
Frank Thomas Materia
DYDan Yaniv
Dan Yaniv
Cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers worldwide, with an incidence that has increased over the past 30 years. Although usually curable with excision, cSCC can become widely metastatic and aggressive with poor outcomes. Whereas the clinical and radiographic extent of any cancer will always guide selection of treatment modality, pathological features of cSCC also play an important role in determining prognosis and, subsequently, the need for further therapy. Therefore, reviewing and summarizing the current literature regarding pathological prognostic indicators of cSCC is essential to improving clinical outcomes. The present literature review yielded depth of invasion, surgical margins, perineural invasion, extranodal extension, lymphovascular invasion, tumor grade, tumor subtype, premalignant lesions, and molecular markers as key prognostic indicators, all with varying recommendations for adjuvant therapy. Notably, some of these factors have not been incorporated into either the American Joint Committee on Cancer staging system (8th edition) or National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for cSCC. This review highlights a need for further research into these prognostic indicators and their role in determining the need for adjuvant treatment in head and neck cSCC.

31 January 2025 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
NWNaomi C. Wang
Naomi C. Wang
URUma Ramesh
Uma Ramesh
MFMaria Feucht
Maria Feucht
RARahul Alapati
Rahul Alapati
SWSarah F. Wagoner
Sarah F. Wagoner
ABAndrés M. Bur
Andrés M. Bur

17 February 2025 in Head & Neck
Verified
Journal Article
Closed access
URUma Ramesh
Uma Ramesh
ANAntonio Bon Nieves
Antonio Bon Nieves
MFMaria Feucht
Maria Feucht
NWNaomi Wang
Naomi Wang
RARahul Alapati
Rahul Alapati
ABAndrés M. Bur
Andrés M. Bur